Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $754.34 | 23 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Amgen Inc. | $143.32 | 2 | $0 (2024) |
| GENZYME CORPORATION | $113.75 | 1 | $0 (2024) |
| Edwards Lifesciences Corporation | $98.42 | 1 | $0 (2023) |
| ABBVIE INC. | $75.26 | 3 | $0 (2024) |
| Lilly USA, LLC | $66.24 | 3 | $0 (2024) |
| Merck Sharp & Dohme LLC | $47.92 | 2 | $0 (2024) |
| GlaxoSmithKline, LLC. | $40.97 | 2 | $0 (2024) |
| Novo Nordisk Inc | $33.10 | 2 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $31.26 | 2 | $0 (2024) |
| Phathom Pharmaceuticals, Inc. | $26.56 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $455.51 | 17 | GENZYME CORPORATION ($113.75) |
| 2023 | $298.83 | 6 | Amgen Inc. ($124.98) |
All Payment Transactions
23 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), SHINGRIX | Food and Beverage | In-kind items and services | $16.26 | General |
| Category: RESPIRATORY | ||||||
| 11/20/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $26.56 | General |
| Category: GASTROENTEROLOGY | ||||||
| 11/06/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $18.63 | General |
| Category: Neuropsychiatry | ||||||
| 10/30/2024 | Xeris Pharmaceuticals, Inc. | KEVEYIS (Drug) | Food and Beverage | In-kind items and services | $23.81 | General |
| Category: Carbonic anhydrase inhibitor | ||||||
| 10/23/2024 | E.R. Squibb & Sons, L.L.C. | CAMZYOS (Drug) | Food and Beverage | Cash or cash equivalent | $16.33 | General |
| Category: Cardiovascular | ||||||
| 10/16/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $19.47 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), VAXNEUVANCE, CAPVAXIVE | Food and Beverage | In-kind items and services | $23.94 | General |
| Category: VACCINE | ||||||
| 10/02/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $20.19 | General |
| Category: Diabetes | ||||||
| 09/18/2024 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $27.97 | General |
| Category: NEUROSCIENCE | ||||||
| 07/24/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.77 | General |
| Category: Biological | ||||||
| 07/16/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $24.71 | General |
| Category: RESPIRATORY | ||||||
| 06/12/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $16.75 | General |
| Category: Respiratory | ||||||
| 05/08/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $17.81 | General |
| Category: Diabetes | ||||||
| 04/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.34 | General |
| Category: Inflammation | ||||||
| 03/12/2024 | GENZYME CORPORATION | ENJAYMO (Biological) | Food and Beverage | In-kind items and services | $113.75 | General |
| Category: Hematology | ||||||
| 02/07/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $28.24 | General |
| Category: Diabetes | ||||||
| 01/24/2024 | Merck Sharp & Dohme LLC | GARDASIL (Biological), CAPVAXIVE, GARDASIL 9 | Food and Beverage | In-kind items and services | $23.98 | General |
| Category: VACCINE | ||||||
| 11/22/2023 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2023 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $13.63 | General |
| Category: Diabetes | ||||||
| 10/18/2023 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $19.80 | General |
| Category: NEUROSCIENCE | ||||||
| 10/04/2023 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $14.51 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 08/09/2023 | Edwards Lifesciences Corporation | — | Food and Beverage | In-kind items and services | $98.42 | General |
| 07/26/2023 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $124.98 | General |
| Category: Cardiology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 2 | 38 | 38 | $9,818 | $3,237 |
All Medicare Procedures & Services
2 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 22 | 22 | $7,018 | $2,303 | 32.8% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 16 | 16 | $2,800 | $933.92 | 33.4% |
About Madison Beardmore
Madison Beardmore is a Physician Assistant healthcare provider based in Coraopolis, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/20/2023. The National Provider Identifier (NPI) number assigned to this provider is 1225713951.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Madison Beardmore has received a total of $754.34 in payments from pharmaceutical and medical device companies, with $455.51 received in 2024. These payments were reported across 23 transactions from 14 companies. The most common payment nature is "Food and Beverage" ($754.34).
As a Medicare-enrolled provider, Beardmore has provided services to 38 Medicare beneficiaries, totaling 38 services with total Medicare billing of $3,237. Data is available for 1 year (2023–2023), covering 2 distinct procedure/service records.
Practice Information
- Specialty Physician Assistant
- Location Coraopolis, PA
- Active Since 06/20/2023
- Last Updated 01/15/2025
- Taxonomy Code 363A00000X
- Entity Type Individual
- NPI Number 1225713951
Products in Payments
- Repatha (Biological) $124.98
- ENJAYMO (Biological) $113.75
- QULIPTA (Drug) $75.26
- MOUNJARO (Drug) $66.24
- GARDASIL (Biological) $47.92
- Ozempic (Drug) $33.10
- VOQUEZNA (Drug) $26.56
- TRELEGY ELLIPTA (Drug) $24.71
- KEVEYIS (Drug) $23.81
- Veozah (Drug) $18.77
- INGREZZA (Drug) $18.63
- Otezla (Drug) $18.34
- AIRSUPRA (Drug) $16.75
- CAMZYOS (Drug) $16.33
- AREXVY (Drug) $16.26
- FARXIGA (Drug) $14.51
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.